Premium
ETF Series Solutions Trust Range Cancer Therapeutics (CNCR)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Fin d'année 31 Août 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -0.223 | -0.353 | -28.836 | 28.912 | 13.443 | -51.915 | -28.069 | 23.297 |
| Return on Equity (%) | -0.223 | -0.353 | -29.158 | 29.312 | 13.452 | -51.95 | -28.089 | 23.312 |
| Return on Invested Capital (%) | -3500 | 3540 | 2160 | 1388.235 | 5533.333 | -400 | -538.462 | -1400 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 25.686 | 25.727 | 19.54 | 26.862 | 30.648 | 15.489 | 12.05 | 15.049 |
| Earnings Per Share | -0.044 | -0.077 | -7.778 | 7.278 | 3.93 | -11.719 | -5.771 | 3.03 |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | -0.001 | -0.003 | -0.001 | -0.01 | 0.006 | 0.021 | -0.006 | 0.023 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | -0.044 | 0.167 | -7.778 | 7.278 | 4.228 | -11.011 | -5.771 | 3.03 |
| Fin d'année 31 Août 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | 1,6M | 2,3M | 1,75M | 1,5M | 1,45M | 1,5M | 800k | 881k |
| Fin d'année 31 Août 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Actions en circulation | N/A | |||||||
| Return on Assets (%) | N/A | |||||||
| Return on Equity (%) | N/A | |||||||
| Return on Invested Capital (%) | N/A | |||||||
| Operating Margin (%) | N/A | |||||||
| Net Profit Margin (%) | N/A | |||||||
| Sales Per Share | N/A | |||||||
| Book Value Per Share | N/A | |||||||
| Earnings Per Share | N/A | |||||||
| Cash Per Share | N/A | |||||||
| Working Capital Per Share | N/A | |||||||
| Operating Profit Per Share | N/A | |||||||
| EBIT Per Share | N/A | |||||||
| EBITDA Per Share | N/A | |||||||
| Free Cash Flow Per Share | N/A | |||||||
| Current Ratio | N/A | |||||||
| Quick Ratio | N/A | |||||||
| Inventory Turnover (Days) | N/A |
| Capitalisation boursière | 9,54M |
| Ratio cours/bénéfice | 3,57 |
| Ratio prix/ventes | 866,4 |
| Ratio prix/liquidités | 0 |
| Ratio prix/valeur comptable | 0,72 |
| Rendement de dividende | - |
| Actions en circulation | 881k |
| Volume moyen (1 semaine) | 625 |
| Volume moyen (1 mois) | 2,14k |
| Variation sur 52 semaines | -35,02% |
| Plus haut sur 52 semaines | 16,781 |
| Plus bas sur 52 semaines | 10,44 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
